Search clinical trials for: VALSARTAN HYDROCHLOROTHIAZIDE

Total 834 results

William Beaumont Hospitals
Novartis Pharmaceuticals

Withdrawn

Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

Hypertension | Diabetes Type 2

United States
GlaxoSmithKline

Terminated

GSK2251052 in Complicated Urinary Tract Infection

Infections, Urinary Tract

France, United States, Russian Federation, Spain, Greece, Canada
University of Oulu

Completed

Effect of Licorice and Hydrochlorothiazide on Plasma Potassium

Hypokalemia

Finland
Novartis Pharmaceuticals

Completed

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure

Hypertension

United States, Hungary, Poland, Turkey, Belgium, France, Germany, India, Italy, Slovakia, Sweden
Boehringer Ingelheim

Completed

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

Hypertension
Boehringer Ingelheim

Completed

Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension

Hypertension

United States, Bulgaria, China, France, Georgia, Korea, Republic of, Romania, Russian Federation
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genetic Epidemiology of Responses to Antihypertensives (GERA)

Heart Diseases | Cardiovascular Diseases | Hypertension

United States
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

Hypertension | Metabolic Syndrome

Spain, Italy, Russian Federation, Norway, France, Germany
Yuhan Corporation

Not yet recruiting

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
University of Florida
Abbott

Completed

INVEST: INternational VErapamil SR Trandolapril STudy

Coronary Artery Disease | Hypertension

United States
Takeda

Completed

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Hypertension

United States, Mexico, Peru, Brazil, Argentina, Puerto Rico
Ospedale San Raffaele

Unknown

Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT) (PGX-HT)

Hypertension

Italy
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan Achieving SBP Target (FAST) Study (FAST)

Essential,Hypertension

Korea, Republic of
Cheng-Hsin General Hospital

Completed

Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy

Heart Failure | Hypotension

Taiwan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

Essential Hypertension

China, Korea, Republic of, Taiwan, Hong Kong, Thailand, Philippines, Singapore
James J. Peters Veterans Affairs Medical Center

Completed

A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride

Orthostatic Hypotension | Spinal Cord Injury

United States
University of Florida
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study) (MEAD)

Hypertension

United States
Uppsala University

Completed

The Precision Hypertension Care Study (PHYSIC)

Hypertension

Sweden
Umeå University
AstraZeneca; Sahlgrenska University Hospital, Sweden

Completed

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

Hypertension | Obesity

Sweden
Novartis Pharmaceuticals

Completed

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

Chronic Heart Failure With Reduced Ejection Fraction

Germany
Novartis Pharmaceuticals

Completed

Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

Mild to Moderate Hypertension

Germany
Chinese PLA General Hospital

Unknown

Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

Chronic Kidney Disease

China
Vanderbilt University Medical Center

Active, not recruiting

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

Hypertension

United States
Assistance Publique - Hôpitaux de Paris

Completed

Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

Healthy

France
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan/ HCTZ Fixed Dose Combination Compared With Its Monocomponents in Healthy Male Volunteers II

Healthy
Brigham and Women's Hospital
National Institutes of Health (NIH)

Completed

Aldosterone and Vascular Disease in Diabetes Mellitus

Diabetes Mellitus | Albuminuria | Endothelial Dysfunction

United States
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

Non Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
University of Oxford

Recruiting

REward Processing And Citalopram Study (REPAC)

Anhedonia

United Kingdom
Novartis Pharmaceuticals

Completed

COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure (CONFIDENCE-HF)

Heart Failure | Erectile Dysfunction | Heart Failure, Systolic

Germany
Guangdong Provincial People's Hospital

Completed

A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

Glomerulonephritis | IGA Nephropathy

China
Kocaeli University

Completed

Nutrition for Colorectal Cancer Patients and Neutrophil Functions

Colorectal Cancer | Malnutrition

Turkey
University of California, San Diego

Completed

Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic (guanhctz)

Obstructive Sleep Apnea
Sherief Abd-Elsalam

Recruiting

Statins and ARBs on Rheumatoid Activity

Rheumatoid Arthritis

Egypt
Military Institute of Medicine, Poland

Completed

Non-invasive Haemodynamic Assessment in Hypertension (FINE-PATH)

Arterial Hypertension

Poland
Boehringer Ingelheim

Completed

Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy Subjects

Healthy
Guangdong Provincial People's Hospital

Unknown

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Type 2 Diabetes Mellitus | Nephropathy

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan

Hypertension

United States, Spain, Philippines, Guatemala, Russian Federation, Argentina, Puerto Rico
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction (PARALLEL-HF)

Heart Failure With Reduced Ejection Fraction (HF-rEF)

Japan
Novartis Pharmaceuticals

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure

Pediatric Heart Failure

United States, Italy, Croatia, Japan, Saudi Arabia, Spain, Austria, Korea, Republic of, Germany, Thailand, Canada, Bulgaria, India, Russian Federation, Turkey, France, Switzerland, China, Taiwan, Lebanon, Poland, Argentina, Hungary, P... and more
Peking Union Medical College Hospital

Unknown

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy (HCQIgAN)

Primary IgA Nephropathy

China
GlaxoSmithKline

Withdrawn

A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions

Healthy Volunteers
Novartis

Completed

A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension

Essential Hypertension

Spain, United States, Belgium, Egypt, Germany, Poland, Slovakia, Turkey
Guangdong Provincial People's Hospital

Completed

A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein (ANTI-UPRO)

Chronic Kidney Diseases

China
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

Hypertension
Novartis

Completed

An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

Hypertension

United States, Belgium, Denmark, Finland, Germany, Iceland, India, Switzerland
Biomedis International Ltd.

Unknown

Recurrent Stroke Prevention Clinical Outcome Study (RESPECTS)

Stroke | Hypertension | Blood Pressure

Japan
Novartis Pharmaceuticals

Completed

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg (EXPLOR)

Hypertension

France
Novartis

Completed

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Essential Hypertension ( Mild to Moderate)

Romania, Slovakia, Hungary, France
Anna Posadzy-Małaczyńska

Completed

Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

Hypertension | Menopause | Hyperuricemia
Boehringer Ingelheim

Completed

Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients

Hypertension

3

Subscribe